Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg Film Coated Tablets

国家: 英国

语言: 英文

来源: VMD (Veterinary Medicines Directorate)

有效成分:

Nitroscanate

可用日期:

Elanco Europe Ltd

ATC代码:

QP52AX01

INN（国际名称）:

Nitroscanate

药物剂型:

Film-coated tablet

处方类型:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

治疗组:

Dogs

治疗领域:

Anthelmintic

授权状态:

Expired

授权日期:

2000-06-30

产品特点

Revised: November 2018
AN: 00829/2018
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar One Dose Wormer for Small Dogs and Puppies, 100 mg film-coated
tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
100
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet, with
‘kx’ imprinted on one
side and ‘CGV’ on the other.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in small dogs and puppies up to
6 kg. It is
highly effective in a single dose against common canine nematodes and
cestodes
in the UK: _Toxocara canis, Toxascaris leonina, Ancylostoma caninum,
Uncinaria _
_stenocephala, Taenia ovis, Taenia hydatigena, Taenia pisiformis _and
_Dipylidium _
_caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus _
_granulosus._
4.3
CONTRAINDICATIONS
Do not administer if your dog is sick or recovering from an illness.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: November 2018
AN: 00829/2018
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Do not repeat treatment if vomiting occurs shortly after dosing.
ii.
Special precautions to be taken by the person administering the
medicinal
product to animals
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting.
Do not repeat treatment if vomiting occurs shortly after dosing.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at the
same time and as frequently as puppies up to 12 weeks of age (i.e. 2,
4, 6, 8,
12 weeks).
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO B